Acupuncture versus sham acupuncture in the treatment of insomnia for patients with Parkinson's disease: a randomized controlled clinical trial

针灸与假针灸治疗帕金森病患者失眠症的随机对照临床试验

阅读:2

Abstract

BACKGROUND: Parkinson's disease-related insomnia (PD-I) has a profound impact on the overall well-being of patients. The findings of previous studies suggested that acupuncture may potentially improve the quality of sleep-in patients with PD. However, the clinical evidence to assess the effectiveness of acupuncture in managing PD-I remains undisclosed. METHODS: In this randomized controlled trial, we enrolled 60 eligible participants between November 24, 2023 and June 18, 2024. Final follow-up was September 20, 2024. Participants with PD-I were allocated randomly (1:1) to the true acupuncture (TA) group or sham acupuncture (SA) group. The primary outcome was the change in the Parkinson Disease Sleep Scale (PDSS) score from baseline to week 16. The secondary outcomes included the assessment of insomnia, movement disorders, drug withdrawal rate and adverse effect were also recorded. RESULTS: The sleep quality rate of the TA group showed an increase at the 4th week, characterized by a notable rise in the proportion of scores within the range of 91-120 and a substantial decrease in scores ranging from 0-60, as compared to the SA group. Moreover, there was a significantly higher change observed in PDSS score for the TA group compared to the SA group, with a difference of 21.4 points (95% CI, 15.6 to 27.2), and this disparity remained consistent throughout the follow-up period until week 16. From baseline to week 4, the Pittsburgh Sleep Quality Index (PSQI) decreased to 8.9 points (95% CI, 3.6 to 14.2) in the TA group and 10.8 points (95% CI, 4.3 to 17.3) in the SA group. The TA group presented a reduction in time to sleep and an increase in both actual sleep duration and sleep efficiency from baseline to week 4 and week 8. CONCLUSION: The findings of this study suggest that acupuncture may enhance the management of patients with PD-I, thereby providing clinical evidence for the safety and efficacy evaluation of acupuncture. TRIAL REGISTRATION: This trial has been registered at Chinese Clinical Trial Registry (ChiCTR2300077729). Submitted 18 July 2023, Registered 17 November 2023.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。